http://ift.tt/eA8V8J
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced it has initiated the borrowing of the third tranche under Senseonics’ previously announced term loan facility with Oxford Finance and Silicon Valley Bank. The third tranche of $5 million was triggered by the first sale of Senseonic
March 31, 2017 at 01:48AM
http://ift.tt/2nAOEnC
from
http://ift.tt/2nAOEnC
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment